Koehn F M, Miska W, Schill W B, Weidner W, Weiske W H
Center of Dermatology and Andrology, Justus Liebig University Giessen, Germany.
Arch Androl. 1993 Nov-Dec;31(3):217-22. doi: 10.3109/01485019308988402.
Vasoactive intestinal polypeptide (VIP) has been suggested to play a role as a nonadrenergic, noncholinergic neurotransmitter or neuromodulator involved in the process of erection. Until now, data about fluctuating concentrations of VIP in corpus cavernosum (CC) blood have been controversial. The present study describes a modified radioimmunoassay method that was developed in our laboratory for the determination of VIP in plasma. Examination of 12 patients suffering from impotentia coeundi (6 men with psychogenic impotence, 2 with induratio penis plastica, and 4 with impotence of vascular origin) showed that the concentrations of VIP in corpus cavernosum blood during pharmacologically induced erection did not increase in organically healthy men or in men with impotentia coeundi of vascular origin. The VIP concentrations in peripheral venous blood and those in CC blood were similar.
血管活性肠肽(VIP)被认为作为一种非肾上腺素能、非胆碱能神经递质或神经调节剂参与勃起过程。到目前为止,关于海绵体(CC)血液中VIP浓度波动的数据一直存在争议。本研究描述了一种在我们实验室开发的用于测定血浆中VIP的改良放射免疫分析方法。对12例患有性交不能症的患者(6例患有心因性阳痿,2例患有阴茎硬结症,4例患有血管性阳痿)的检查表明,在药物诱导勃起期间,海绵体血液中VIP的浓度在器官功能正常的男性或患有血管性性交不能症的男性中并未升高。外周静脉血中的VIP浓度与CC血液中的相似。